Cargando…
A WHO tool for risk‐based decision making on blood safety interventions
BACKGROUND: Risk‐based decision making is increasingly recognized as key to support national blood policy makers and blood operators concerning the implementation of safety interventions, especially to address emerging infectious threats and new technology opportunities. There is an urgent need for...
Autores principales: | Janssen, Mart P., Nuebling, C. Micha, Lery, François‐Xavier, Maryuningsih, Yuyun S., Epstein, Jay S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898802/ https://www.ncbi.nlm.nih.gov/pubmed/33368381 http://dx.doi.org/10.1111/trf.16231 |
Ejemplares similares
-
Performance profile of an updated safety measure rapid assay for bacteria in platelets
por: Vallejo, Remo P., et al.
Publicado: (2020) -
Economic implications of FDA platelet bacterial guidance compliance options: Comparison of single‐step strategies
por: Prioli, Katherine M., et al.
Publicado: (2022) -
Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay
por: Levin, Andrew E, et al.
Publicado: (2014) -
Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay
por: Levin, Andrew E., et al.
Publicado: (2016) -
Evaluation of a new West Nile virus nucleic acid test for screening of blood donations
por: Stanley, Jean, et al.
Publicado: (2018)